2
Contraindications & Bleeding Risk
General Contraindications
- Absolute: Uncorrectable coagulopathy, no safe access window, uncooperative patient
- Relative: Anticoagulation (hold per SIR guidelines), severe emphysema (lung — high PTX risk), hydatid cyst (anaphylaxis risk), suspected vascular lesion (hemangioma, AVM), interposed bowel
SIR Bleeding Risk by Target
| Target | SIR Category | INR | Platelets |
|---|---|---|---|
| Lung (superficial) | Cat 2 | <1.5 | >50K |
| Liver | Cat 2–3 | <1.5 | >50K |
| Kidney (native) | Cat 3 | <1.5 | >50K |
| Bone / Soft tissue | Cat 2 | <1.5 | >50K |
| Thyroid (FNA) | Cat 1 | <3.0 | >20K |
3
Shared Complications
Immediate
- Bleeding / hematoma — most common across all targets; usually self-limited
- Pneumothorax (lung biopsy) — 15–25% incidence, ~5% require chest tube
- Pain at biopsy site
- Vasovagal reaction
Delayed
- Tumor seeding along needle tract — rare, risk reduced with coaxial technique
- Infection / abscess — rare with sterile technique
- Non-diagnostic result — may require repeat biopsy or surgical excision
- Organ-specific: hemothorax (lung), bile leak (liver), hematuria (kidney), fracture (bone)
4
Procedures in This Family
9
References & Resources
Primary sources · Key data · Related procedures
Key Guidelines
- ACR Practice Parameter for Image-Guided Percutaneous Needle Biopsy (2021)
- SIR quality improvement guidelines for image-guided biopsies
Primary References
- Gupta S, Wallace MJ, Cardella JF, et al. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol. 2010;21(7):969–975.
- Monfardini L, Preda L, Aurilio G, et al. CT-guided biopsy in cancer patients: review of 296 cases. Eur Radiol. 2011;21(11):2399–2407.
- Fischbach F, Knollmann F, Griesser V, et al. Detection of pulmonary nodules by multislice computed tomography. Eur Radiol. 2003;13(10):2378–2383.